BRK.B vs DGX · rev $371.44B vs P/E 22, rev $5.94B
BRK.B (BRK.B) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
BRK.B currently screens at market cap $0. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the BRK.B and DGX stock pages for the full models.
Not investment advice.